tiprankstipranks
Biolase (DE:BTH)
FRANKFURT:BTH

Biolase Financial Statements

Biolase Financial Overview

Biolase's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Biolase is scheduled to report earnings on August 11, 2022, and the estimated EPS forecast is $-0.63. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 10.17M$ 12.41M$ 9.53M$ 9.13M$ 8.12M
Gross Profit$ 4.73M$ 4.91M$ 4.84M$ 4.04M$ 2.74M
EBIT$ -4.33M$ -4.71M$ -2.69M$ -200.00K$ -6.27M
EBITDA$ -4.21M$ -4.59M$ -2.59M$ -109.00K$ -6.18M
Net Income Common Stockholders$ -4.99M$ -5.28M$ -3.29M$ -708.00K$ -7.43M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 17.56M$ 18.85M$ 21.61M$ 29.97M$ 33.38M
Total Assets$ 50.24M$ 55.28M$ 58.51M$ 61.25M$ 63.48M
Total Debt$ 5.30M$ 14.01M$ 14.71M$ 15.58M$ 16.41M
Net Debt$ -12.26M$ -4.84M$ -6.90M$ -14.39M$ -16.98M
Total Liabilities$ 29.64M$ 30.08M$ 28.19M$ 27.99M$ 29.97M
Stockholders Equity$ 10.03M$ 13.85M$ 20.60M$ 25.21M$ 30.32M
Cash Flow
Free Cash Flow$ -8.32M$ -3.42M$ -3.68M$ -3.81M$ -6.51M
Operating Cash Flow$ -8.02M$ -3.10M$ -3.60M$ -3.51M$ -6.50M
Investing Cash Flow$ -304.00K$ -311.00K$ -85.00K$ -303.00K$ -8.00K
Financing Cash Flow$ 0.00$ 68.00K$ 75.00K$ -14.00K$ 29.82M
Currency in USD

Biolase Earnings and Revenue History


Biolase Debt to Assets


Biolase Cash Flow


Biolase Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis